Recently, media reports and pre-print scientific papers on SARS-CoV-2 variants have discussed various genetic mutations in the virus that have occurred. SARS-CoV-2 is the virus…
A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy for its safety and efficacy in people who have mild…
The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results…
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, announced that the fourth iteration of the Adaptive COVID-19…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, launched a study on October 13, 2020, designed to…
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir…
A fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19) has begun enrolling adult volunteers. The trial is designed to…
A Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun. The vaccine,…
NIAID-sponsored phase 1 trial tested mRNA vaccine An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19),…
More than 300 scientists and clinicians from the federal government, industry and academia published a report of their conclusions and recommendations on COVID-19 serology studies…
Study is a wake-up call for the potential of another such outbreak, as vaccination rates plummet during the COVID-19 pandemic. An analysis of the 2018-2019…
The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in the New…
Study provided data for clinical testing to commence. A single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six rhesus macaques from…
Study enrolling adults with mild to moderate COVID-19 in the United States. A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given…
Coronaviruses are a large family of viruses that usually cause mild to moderate upper-respiratory tract illnesses, like the common cold. However, three new coronaviruses have…
Study Supports Clinical Testing Under Way Across U.S. Early treatment with the experimental antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs…
SARS-CoV-2 stability similar to original SARS virus The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and…
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the…